Product Description
Insulin promotes the absorption of glucose from the blood into skeletal muscle cells, liver, and fat. The production and secretion of glucose by the liver is firmly repressed by extraordinary insulin concentrations in the blood. If the sugar level in the body is more than what is required, insulin plays a major role in storing sugar in the liver. This stored sugar is released when the blood sugar level is low or when the body requires more sugar. Diabetes affects the body’s capability to process blood sugar. Gestational diabetes, type 1, and type 2 are three major diabetes types. People living with type 1 diabetes are completely dependent on insulin and have to take artificial insulin on a daily basis. Insulin has to be injected under the skin into the fatty tissue. A wide variety of devices are employed for the supply of insulin, including pens, syringes, injectors, and pumps.
The Insulin Delivery Devices market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.
Considering the influence of COVID-19 on the global Insulin Delivery Devices market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Insulin Delivery Devices Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Insulin Delivery Devices market are:
B. Braun Melsungen AG
Abbott Laboratories
Animas Corporation
Novo Nordisk A/S
F. Hoffmann-La Roche
Insulet
Sanofi
Becton Dickinson
Medtronic, Inc.
Ypsomed Holdings AG
Eli Lilly and Company
Most important types of Insulin Delivery Devices products covered in this report are:
Insulin pumps
Insulin pen
Insulin syringe
Insulin jet
Most widely used downstream fields of Insulin Delivery Devices market covered in this report are:
Diabetes Clinics and Centers
Retail Pharmacy
Hospital Pharmacy
Online Sales
Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.